Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HAVN Life Sciences Inc C.HAVN

Alternate Symbol(s):  HAVLF

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities... see more

Recent & Breaking News (CSE:HAVN)

Canadian Investment Regulatory Organization Trading Halt - HAVN

Canada NewsWire November 10, 2023

CSE Bulletin: Reinstatement - HAVN Life Sciences Inc. (HAVN)

Newsfile January 31, 2023

IIROC Trade Resumption - HAVN

Canada NewsWire January 31, 2023

CSE Bulletin: Suspension - HAVN Life Sciences Inc. (HAVN)

Newsfile January 9, 2023

IIROC Trading Halt - HAVN

Canada NewsWire January 9, 2023

HAVN Life Sciences (CSE:HAVN) announces retail listing with Loblaw (TSX:L)

Trevor Abes  October 31, 2022

HAVN Life Announces Retail Listing With Loblaws Company Ltd.

Canada NewsWire October 27, 2022

IIROC Trade Resumption - HAVN

Canada NewsWire September 20, 2022

HAVN Life Provides Corporate Update

Canada NewsWire September 20, 2022

IIROC Trading Halt - HAVN

Canada NewsWire September 19, 2022

HAVN Life Announces the close of the first tranche of its previously announced Financing Commitment by Alpha Blue Ocean and Warrant Amendments‎ and the Issuance of Shares for Debt

Canada NewsWire August 18, 2022

IIROC Trade Resumption - HAVN

Canada NewsWire August 3, 2022

IIROC Trading Halt - HAVN

Canada NewsWire August 3, 2022

CSE Bulletin: Consolidation - HAVN Life Sciences Inc. (HAVN)

Newsfile August 2, 2022

HAVN Life Announces a 30:1 Consolidation of its Common Shares

GlobeNewswire July 29, 2022

HAVN Life Sciences (CSE:HAVN) to supply psilocybin products for medical psilocybin & data project

Dave Jackson July 28, 2022

HAVN Life Announces Financing Commitment of CAD$9,000,000 through the issuance of Convertible Debentures and Warrants

Canada NewsWire July 21, 2022

HAVN Life Enters Supply Agreement with MPB Group Inc.

Canada NewsWire June 28, 2022

HAVN Life To Be Featured On Viewpoint with Dennis Quaid

PR Newswire June 22, 2022

HAVN Life Announces Changes to the Board of Directors

Canada NewsWire June 14, 2022